Noteworthy - Pharmaceutical Executive

ADVERTISEMENT

Noteworthy

The Active Patient: Faces Of Change

February 1, 2014

Advocacy organizations and individual patients are getting more involved in every facet of the healthcare system, from drug R&D, to federal and state policy all fueled by the hour-to-hour passion of living with a disease.

Drug Coverage, Costs Under Scrutiny

February 1, 2014

Benefits offered by insurance plans on health exchanges and through Medicare are raising concerns about patient access to needed therapies, writes Jill Wechsler.

Managed Markets: Positioning Your Product For Success with Pull Through Strategies

February 1, 2014

A patient-centric approach to drug development delivers the benefits that actually create value.

Product Positioning 2.0

February 1, 2014

Industry and market transformations have dramatically altered when and how products should be positioned for launch, writes Stan Bernard.

Senior Execs' Anti-Social Media Behavior

January 28, 2014

Recent research says social media and messaging apps are continuing to proliferate. But not so with senior execs, who are starting to avoid these networks altogether, says Chris Molloy.

2014: The Year of Digital Pharma?

January 23, 2014

2014 might be the year that pharma finally has to get really serious about digital, at least if the analysts are right. Peter Houston reports.

Innovation: The Moneyball Test

January 21, 2014

Successful innovation now has to align with key metrics of value—can an old baseball metaphor help guide the way?

Pharm Exec's Annual Industry Outlook 2014

January 21, 2014

For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive — muddling through is so yesterday.

Russia's Bet on Biopharma

January 21, 2014

Can innovation trump ideology? Russia faces a stark choice in betting on the visible hand of government in promoting a "world class" biopharmaceutical sector, writes William Looney.

ADVERTISEMENT

Click here